SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001558370-19-002140
Filing Date
2019-03-15
Accepted
2019-03-15 16:01:36
Documents
11
Period of Report
2019-04-25
Effectiveness Date
2019-03-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A def14a.htm DEF 14A 1914940
2 GRAPHIC def14ag001.jpg GRAPHIC 6445
3 GRAPHIC def14ag002.jpg GRAPHIC 822
4 GRAPHIC def14ag003.jpg GRAPHIC 1017
5 GRAPHIC def14ag004.jpg GRAPHIC 52336
6 GRAPHIC def14ag005.jpg GRAPHIC 9190
7 GRAPHIC def14ag006.jpg GRAPHIC 9322
8 GRAPHIC def14ag007.jpg GRAPHIC 10791
9 GRAPHIC def14ag008.jpg GRAPHIC 10424
10 GRAPHIC def14ag009.gif GRAPHIC 120626
11 GRAPHIC def14ag010.gif GRAPHIC 85361
  Complete submission text file 0001558370-19-002140.txt   2339134
Mailing Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072
Business Address 100 TECHNOLOGY CENTER DRIVE STOUGHTON MA 02072 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Filer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37372 | Film No.: 19684995
SIC: 2834 Pharmaceutical Preparations